Stay Smoke-Free Research Study
Researchers at Arch Clinical Trials are conducting a study on staying smoke-free after quitting for adults who have recently stopped smoking.
Fast Facts
Have quit smoking cigarettes in the last month
18-75
Years Old
Compensation
Provided
Conducted in
St. Louis, MO
Study Background
Supporting individuals who have recently quit smoking in maintaining a smoke‑free life
Researchers at Arch Clinical Trials are conducting a study to evaluate whether a new investigational medication can help individuals who have quit smoking within the past month remain smoke‑free, reduce cravings, and manage weight gain that often follows quitting. The study is designed for adults aged 18–75 who have a history of smoking at least 10 cigarettes per day and are motivated to continue living smoke‑free.
Participants will attend scheduled study visits, where they may provide blood samples for safety monitoring and drug level testing, and keep a simple log of study drug injections. In addition to contributing to important research, participants may receive compensation, transportation reimbursement, and complimentary health services such as physician consultation and blood work with results. This study offers both personal health benefits and the opportunity to support advancements in smoking cessation treatments.
Study Background
Supporting individuals who have recently quit smoking in maintaining a smoke‑free life
Researchers at Arch Clinical Trials are conducting a study to evaluate whether a new investigational medication can help individuals who have quit smoking within the past month remain smoke‑free, reduce cravings, and manage weight gain that often follows quitting. The study is designed for adults aged 18–75 who have a history of smoking at least 10 cigarettes per day and are motivated to continue living smoke‑free.
Participants will attend scheduled study visits, where they may provide blood samples for safety monitoring and drug level testing, and keep a simple log of study drug injections. In addition to contributing to important research, participants may receive compensation, transportation reimbursement, and complimentary health services such as physician consultation and blood work with results. This study offers both personal health benefits and the opportunity to support advancements in smoking cessation treatments.
Additional Information
The study is designed to evaluate whether a medication can help people who have recently quit smoking stay smoke‑free, reduce cravings, and avoid post‑quit weight gain.
You may be eligible for this study if you meet the following criteria.
Inclusion Criteria:
You are between 18 and 75 years old.
You have quit smoking within the past 30 days.
You are motivated to remain smoke‑free.
Before quitting, you smoked at least 10 cigarettes per day.
You have a history of smoking for at least 1 year with combustible cigarettes.
You are willing to:
Attend scheduled study visits.
Provide blood samples for safety monitoring and drug level testing.
Keep a log of study drug injections (time and site).
Initial contact: A brief phone screening to review eligibility and answer questions.
Clinic screening visit: Eligibility confirmation, including recent quit status and prior smoking history.
Enrollment: If eligible, you’ll join the study and receive instructions on the investigational medication.
Study procedures: Periodic visits, possible blood samples for safety and drug levels, and maintaining a simple injection log (time and site).
Ongoing support: Regular check‑ins to review your log, monitor progress, and provide study guidance.
Completion: A final visit to assess outcomes and discuss next steps.
Yes, compensation is available for participants.
There is no cost for you to participate in our research study.